Clinical Trial Update: A Study for Identification of Immune Determinants for Response to Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma [NA]

View source ↗

Summary

A Yonsei University-led clinical trial update investigating immune determinants of response to nivolumab in recurrent or metastatic head and neck squamous cell …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Squamous Cell Carcinoma

Drugs mentioned

• nivolumab (nivolumab)

Snippet

Sponsor: Yonsei University | Conditions: Head and Neck Squamous Cell Carcinoma (HNSCC) | NA | Status: ACTIVE_NOT_RECRUITING